These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Multiple Lymph Node Basin Drainage in Trunk Melanoma Is Not Associated with Survival of Sentinel Lymph Node-Positive Patients. Ribero S, Osella Abate S, Pasquali S, Rossi CR, Borgognoni L, Piazzalunga D, Solari N, Schiavon M, Brandani P, Ansaloni L, Ponte E, Silan F, Sommariva A, Bellucci F, Macripò G, Quaglino P, Italian Melanoma Intergroup (IMI). Dermatology; 2017; 233(2-3):205-211. PubMed ID: 28738392 [Abstract] [Full Text] [Related]
43. Frequency and implications of occipital and posterior auricular sentinel lymph nodes in scalp melanoma. Carmichael H, King BBT, Friedman C, Torphy RJ, Medina T, Gleisner A, McCarter MD, Kwak JJ, Kounalakis N. J Surg Oncol; 2019 Dec; 120(8):1470-1475. PubMed ID: 31614003 [Abstract] [Full Text] [Related]
44. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH. Ann Surg Oncol; 2018 Feb; 25(2):356-377. PubMed ID: 29236202 [Abstract] [Full Text] [Related]
45. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004. Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM. Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331 [Abstract] [Full Text] [Related]
48. Integrating the melanoma 31-gene expression profile test with clinical and pathologic features can provide personalized precision estimates for sentinel lymph node positivity: an independent performance cohort. Kriza C, Martin B, Bailey CN, Bennett J. World J Surg Oncol; 2024 Aug 30; 22(1):228. PubMed ID: 39215342 [Abstract] [Full Text] [Related]
52. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, Hagendoorn L, Martin RC, McMasters KM. Am J Surg; 2011 Dec 30; 202(6):659-64; discussion 664-5. PubMed ID: 22137134 [Abstract] [Full Text] [Related]
58. Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma. Maddineni S, Dizon MP, Muralidharan V, Young LA, Sunwoo JB, Baik FM, Swetter SM. Ann Surg Oncol; 2024 Apr 30; 31(4):2737-2746. PubMed ID: 38216800 [Abstract] [Full Text] [Related]
59. Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis? Han D, Han G, Morrison S, Leong SP, Kashani-Sabet M, Vetto J, White R, Schneebaum S, Pockaj B, Mozzillo N, Sondak VK, Zager JS. Surgery; 2020 Sep 30; 168(3):518-526. PubMed ID: 32669204 [Abstract] [Full Text] [Related]
60. Mitotic rate as a predictive factor for positive sentinel lymph nodes in pT1 and pT2 melanomas. Fidanzi C, Bevilacqua M, D'Erme AM, Morganti R, Viacava P, Manzo Margiotta F, Romanelli M, Dini V, Janowska A, Bagnoni G. J Plast Reconstr Aesthet Surg; 2023 Aug 30; 83():215-220. PubMed ID: 37279633 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]